New model could speed up colon cancer research
Introducing genetic mutations with CRISPR offers a fast and accurate way to simulate the disease.
Introducing genetic mutations with CRISPR offers a fast and accurate way to simulate the disease.
Hadley Sikes is bridging the gap between engineering and public policy to solve big social problems at home and abroad.
Koch Institute director advocates support for biomedical research in testimony before the House Committee on Oversight and Government Reform.
“Synthetic biomarkers” could be used to diagnose ovarian cancer months earlier than now possible.
Differences in chromosome number may underlie variation among genetically identical individuals.
Microfluidic device isolates plasma cells from blood rather than bone marrow.
Researchers program RNA nanoparticles that could protect against the virus.
New technique can reveal exposure to aflatoxin, a potent carcinogen, before tumors develop.
New strategy could improve performance of some immune-based drugs.
Expert on long-lived rodents provides insights into research on longevity and cancer resistance.
Computer scientist Regina Barzilay empowers cancer treatment with machine learning.
Takeda's $1 million gift to the MIT Koch Institute will advance research into how the immune system affects cancer.
Portable tool could help scientists learn more about cells’ roles in many diseases.
Biologists link levels of Mena protein to breast cancer cells’ sensitivity to chemotherapy.
Measuring DNA repair capability can reveal tumors’ sensitivity to drugs.